Mucinex Tablet, Extended Release
Product Images NDC 72854-001

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mucinex (NDC 72854-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Reckitt Benckiser Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Back Label (72854 001 Back Label)

Drug Facts panels from Mucinex 12HR Cold and Fever Multi-Symptom extended-release tablets containing naproxen sodium, dextromethorphan hydrobromide, and guaifenesin. The panels include warnings, do not use instructions, precautions, directions for use, storage information, inactive ingredients, and a contact number for questions.*

FDA Label Image

Full Carton Label (72854 001 Front Label)

Mucinex 12HR Cold and Fever Multi-Symptom extended-release tablets containing naproxen sodium 110 mg, dextromethorphan HBr 30 mg, and guaifenesin 600 mg. The package includes 16 tablets and is labeled as a fever, headache, body pain reliever, cough suppressant, chest congestion aid, and mucus thinner. Manufactured by Reckitt Benckiser LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.